Europe — EMA
Noresmea (Norethisterone Acetate, Estradiol)
GNH USA supplies Noresmea (Norethisterone acetate / Estradiol), a estrogen‑progestogen combination for relief of menopausal vasomotor symptoms
Request sourcing
What is Norethisterone Acetate, Estradiol?
Norethisterone acetate and estradiol, the active ingredients in Noresmea, are an estrogen‑progestogen combination presented as a 2 mg estradiol / 1 mg norethisterone acetate tablet for oral use. It relieves menopausal vasomotor symptoms, prevents osteoporosis and treats estrogen deficiency in post‑menopausal women.
GNH USA supplies Noresmea as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is distributed under a prescription‑only status.
What is Norethisterone Acetate, Estradiol used for?
Noresmea, an estrogen‑progestogen combination, is used in hormone replacement therapy for menopausal and estrogen‑deficiency conditions.
- Menopausal vasomotor symptoms: reduces hot flashes, night sweats and related discomfort. - Osteoporosis prevention in post‑menopausal women: helps maintain bone mineral density and reduces fracture risk. - Estrogen deficiency syndrome: alleviates vaginal dryness, mood changes and other deficiency‑related symptoms.
What are the side effects of Norethisterone Acetate, Estradiol?
Adverse reactions may occur with any hormone therapy. The following lists reported events.
Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Breast tenderness: transient swelling or discomfort. - Headache: occasional tension‑type headaches. - Bloating: abdominal distension or fluid retention. - Mood changes: irritability or mild depressive symptoms. - Weight gain: modest increase in body weight.
Serious or Rare Side Effects: - Venous thromboembolism: deep vein thrombosis or pulmonary embolism. - Stroke: cerebrovascular accident, particularly in high‑risk patients. - Myocardial infarction: heart attack risk may increase. - Liver dysfunction: abnormal liver enzymes or hepatitis. - Severe allergic reaction: anaphylaxis, rash, or angioedema. - Endometrial cancer: risk if progestogenic protection is inadequate.
What precautions apply to Norethisterone Acetate, Estradiol?
Before initiating Noresmea, clinicians should consider several safety aspects.
- Cardiovascular assessment: evaluate history of thromboembolic events or cardiovascular disease. - Liver function: monitor hepatic enzymes in patients with liver impairment. - Bone health: assess baseline bone mineral density when used for osteoporosis prevention. - Breast health: perform regular examinations and imaging as indicated. - Pregnancy contraindication: avoid use in pregnant women; discontinue if pregnancy occurs. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.
What does Norethisterone Acetate, Estradiol interact with?
Noresmea can interact with other medicines, affecting efficacy or safety.
Major Interactions (Avoid): - Combined estrogen therapy: additive risk of thromboembolism. - Anticoagulants (e.g., warfarin): may alter anticoagulant effect. - Strong CYP3A4 inducers (e.g., rifampicin): reduce hormone plasma levels.
Moderate Interactions (Monitor Closely): - SSRIs/SNRIs: may diminish hot‑flash relief. - Antihypertensives: possible fluid retention influencing blood pressure. - Thyroid hormone replacement: may affect hormone binding and dosage requirements.



